Early detection

Shifting cancer care to an earlier stage

The earlier cancer is detected, the greater the opportunity to improve outcomes. Our researchers develop innovative technologies and personalized screening approaches to identify cancer at its earliest stages. Equally important, we aim to distinguish aggressive disease from lesions that can be safely monitored, reducing unnecessary treatment. Through close collaboration between research and clinical implementation, we work toward screening programs that are both effective and precise.

The Netherlands Cancer Institute, in collaboration with the AVL Center for Early Diagnostics, offers our researchers the best infrastructure to develop and optimize personalized screening and test novel techniques to detect cancer at an early stage of development.

How does cancer develop in the human body?

Which biomarkers can detect cancer effectively and efficiently at an early stage?

How can we set up a personalized screening for various cancer types?

We aim to translate fundamental knowledge into early detection programs to improve outcomes for cancer patients and eventually prevent cancer development.

Marjanka Schmidt

Research into early detection at the Netherlands Cancer Institute

In this video, theme leader Marjanka Schmidt, PhD student Hristina Hristova, medical geneticist Irma van de Beek, and researcher Beatriz Carvalho show you their research into ways to detect cancer at an earlier stage. If the illness is detected early, treatment can be less invasive and the odds of recovery are higher.